Treating the cardiometabolic syndrome: an opportunity to provide comprehensive cardiovascular risk reduction.
Basile
Jan
J
Ralph H. Johnson VA Medical Center and Division of General Internal Medicine/Geriatrics, Medical University of South Carolina, Charleston, SC 29401, USA. jan.basile@med.va.gov
Houston
Mark
M
Ferrario
Carlos M
CM
D000959:Antihypertensive Agents / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000209:etiology / Q000517:prevention & control*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy* / Q000209:etiology; D050171:Dyslipidemias / Q000150:complications / Q000188:drug therapy; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D024821:Metabolic Syndrome / Q000150:complications / Q000188:drug therapy*; D009765:Obesity / Q000150:complications / Q000188:drug therapy; D017410:Practice Guidelines as Topic; D018570:Risk Assessment; D012307:Risk Factors
D000959:Antihypertensive Agents; D007004:Hypoglycemic Agents; D000960:Hypolipidemic Agents